PURPLE BIOTECH LTD's ticker is and the CUSIP is 74638P909. A total of 2 filers reported holding PURPLE BIOTECH LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $20,580 | -84.3% | 14,700 | -80.2% | 0.00% | – |
| Q1 2023 | $130,768 | +1088.8% | 74,300 | +1328.8% | 0.00% | – |
| Q3 2022 | $11,000 | -88.7% | 5,200 | -87.2% | 0.00% | – |
| Q2 2022 | $97,000 | -40.9% | 40,500 | -2.2% | 0.00% | – |
| Q1 2022 | $164,000 | +0.6% | 41,400 | -1.4% | 0.00% | – |
| Q4 2021 | $163,000 | -17.7% | 42,000 | -3.4% | 0.00% | – |
| Q3 2021 | $198,000 | +25.3% | 43,500 | +34.3% | 0.00% | – |
| Q2 2021 | $158,000 | +829.4% | 32,400 | +710.0% | 0.00% | – |
| Q1 2021 | $17,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 40,500 | $97,000 | 0.00% |